litlas
Log inCreate account

Joachim R. Kalden

Active 1976–2019

77
Papers
31,065
Citations
75
h-index
77
i10-index

Citations

Citations per year for Joachim R. Kalden1976: 1 citations1977: 3 citations1978: 4 citations1979: 3 citations1980: 1 citations1981: 1 citations1983: 2 citations1984: 1 citations1985: 5 citations1986: 5 citations1987: 4 citations1988: 7 citations1990: 4 citations1991: 9 citations1992: 8 citations1993: 23 citations1994: 17 citations1995: 32 citations1996: 52 citations1997: 81 citations1998: 101 citations1999: 166 citations2000: 208 citations2001: 250 citations2002: 363 citations2003: 340 citations2004: 411 citations2005: 464 citations2006: 458 citations2007: 467 citations2008: 485 citations2009: 467 citations2010: 442 citations2011: 384 citations2012: 326 citations2013: 265 citations2014: 245 citations2015: 217 citations2016: 201 citations2017: 184 citations2018: 170 citations2019: 469 citations2020: 428 citations2021: 325 citations2022: 276 citations2023: 153 citations2024: 249 citations2025: 85 citations2026: 3 citations1982: no citations, so this year is not shown1989: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,481 citing papers, 23.3% of this breakdownUnited Kingdom: 1,037 citing papers, 9.7% of this breakdownGermany: 881 citing papers, 8.3% of this breakdownNetherlands: 578 citing papers, 5.4% of this breakdownFrance: 457 citing papers, 4.3% of this breakdownChina: 441 citing papers, 4.2% of this breakdownItaly: 438 citing papers, 4.1% of this breakdownCanada: 396 citing papers, 3.7% of this breakdownJapan: 372 citing papers, 3.5% of this breakdownSweden: 309 citing papers, 2.9% of this breakdownSpain: 269 citing papers, 2.5% of this breakdownAustralia: 244 citing papers, 2.3% of this breakdown
0%23.3%Other 25.8%

Institutions

Fields

  • Medicine61.4%
  • Immunology and Microbiology22.7%
  • Biochemistry, Genetics and Molecular Biology12.9%
  • Neuroscience0.9%
  • Engineering0.3%
  • Computer Science0.3%
  • Other1.5%

Topics

  • Rheumatoid Arthritis Research and Therapies11.4%
  • Systemic Lupus Erythematosus Research6%
  • Spondyloarthritis Studies and Treatments4.8%
  • T-cell and B-cell Immunology3.8%
  • Autoimmune and Inflammatory Disorders Research3.5%
  • Immune Cell Function and Interaction3%
  • Other67.5%

Coauthors

All papers

Open in search
  1. Immunosuppressive effects of apoptotic cells

    Authors: Reinhard Voll, Martin Herrmann, Edith Roth, C. Stach, Joachim R. Kalden, Irutė Girkontaitė - Nature 1997 cited by 1,797

  2. A simplified disease activity index for rheumatoid arthritis for use in clinical practice

    Authors: Josef S Smolen, FC Breedveld, Michael Schiff, Joachim R. Kalden, Paul Emery, Gérard Eberl, P.L. van Riel, Peter Tugwell - Lara D. Veeken 2003 cited by 1,067

  3. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

    Authors: Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld, Daniel E. Fürst, Joachim R. Kalden, Michael H. Weisman, Josef S. Smolen, Paul Emery, Gregory R. Harriman, Marc Feldmann, Peter E. Lipsky - The Lancet 1999 cited by 2,357

  4. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

    Authors: Ravinder N. Maini, Ferdinand C. Breedveld, Joachim R. Kalden, Josef S Smolen, Diana Davis, J. D. Macfarlane, Christian Antoni, Burkhard F. Leeb, Michael J. Elliott, James N. Woody, T Schaible, Marc Feldmann - Arthritis & Rheumatism 1998 cited by 1,639

  5. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus

    Authors: Martin Herrmann, Reinhard Voll, Otmar Zoller, M. Hagenhofer, Botond B. Ponner, Joachim R. Kalden - Arthritis & Rheumatism 1998 cited by 832

  6. Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

    Authors: Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair, Daniel E. Fürst, Ferdinand C. Breedveld, Joachim R. Kalden, Josef S Smolen, Michael H. Weisman, Paul Emery, Marc Feldmann, Gregory R. Harriman, Ravinder N. Maini - New England Journal of Medicine 2000 cited by 3,019

  7. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

    Authors: Kirsten Neubert, Silke Meister, Katrin Moser, Florian Weisel, Damián Maseda, Kerstin Amann, Carsten Wiethe, Thomas Winkler, Joachim R. Kalden, Rudolf A. Manz, Reinhard Voll - Nature Medicine 2008 cited by 576

  8. Immunogenicity and loss of response to TNF inhibitors: implications for rheumatoid arthritis treatment

    Authors: Joachim R. Kalden, Hendrik Schulze‐Koops - Nature Reviews Rheumatology 2017 cited by 182

  9. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

    Authors: Michael J. Elliott, Ravinder N. Maini, Marc Feldmann, Joachim R. Kalden, Christian Antoni, Josef S Smolen, Burkhard F. Leeb, F. C. Breedveld, J. D. Macfarlane, J. A. Bijl, James N. Woody - The Lancet 1994 cited by 1,704

  10. The balance of Th1/Th2 cytokines in rheumatoid arthritis

    Authors: Hendrik Schulze‐Koops, Joachim R. Kalden - Best Practice & Research Clinical Rheumatology 2001 cited by 274

  11. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus

    Authors: Irith Baumann, Wasilis Kolowos, Reinhard Voll, Bernhard Manger, Udo S. Gaipl, Winfried Neuhuber, Thomas Kirchner, Joachim R. Kalden, Martin Herrmann - Arthritis & Rheumatism 2002 cited by 557

  12. Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019

    Authors: Kevin Winthrop, Michael E. Weinblatt, Joan M. Bathon, Gerd R Burmester, Philip J. Mease, Leslie J. Crofford, Vivian P. Bykerk, Maxime Dougados, James T. Rosenbaum, Xavier Mariette, Joachim Sieper, Fritz Melchers, Bruce N. Cronstein, F C Breedveld, Joachim R. Kalden, Josef S Smolen, Daniel E. Furst - Annals of the Rheumatic Diseases 2019 cited by 111

  13. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

    Authors: Lars Klareskog, Désirée van der Heijde, J Jäger, Andrew Gough, Joachim R. Kalden, Michel Malaise, Emilio Martín Mola, Karel Pavelká, J Sany, L. Settas, Joseph Wajdula, Ronald Pedersen, Saeed Fatenejad, Marie Sanda - The Lancet 2004 cited by 1,772

  14. Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE

    Authors: Vilma Urbonaviciute, Barbara G. Fürnrohr, Silke Meister, Luis E. Muñoz, Petra Heyder, Francesco De Marchis, Marco E. Bianchi, Carsten J. Kirschning, Hermann Wagner, Angelo A. Manfredi, Joachim R. Kalden, Georg Schett, Patrizia Rovere‐Querini, Martin Herrmann, Reinhard Voll - The Journal of Experimental Medicine 2008 cited by 508

  15. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial

    Authors: E. William St. Clair, Désirée van der Heijde, Josef S Smolen, Ravinder N. Maini, Joan M. Bathon, Paul Emery, Edward Keystone, Michael Schiff, Joachim R. Kalden, Ben Wang, Kimberly L. DeWoody, Roberta Weiss, Daniel L. Baker, Active‐Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset Study Group - Arthritis & Rheumatism 2004 cited by 1,166

  16. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)

    Authors: Christian Antoni, Arthur Kavanaugh, Bruce Kirkham, Zuhre Tutuncu, Gerd R Burmester, Udo Schneider, Daniel E. Fürst, Jerry A. Molitor, Edward Keystone, Dafna D. Gladman, Bernhard Manger, Siegfried Wassenberg, Ralf Weier, Daniel J. Wallace, Michael H. Weisman, Joachim R. Kalden, Josef S Smolen - Arthritis & Rheumatism 2005 cited by 643

  17. Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade

    Authors: Josef S Smolen, C. Han, Désirée van der Heijde, Paul Emery, Joan M. Bathon, Ed Keystone, Ravinder N. Maini, Joachim R. Kalden, Daniel Aletaha, Daniel Baker, Jie Han, M Bala, E. William St. Clair - Annals of the Rheumatic Diseases 2008 cited by 237

  18. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti–tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study

    Authors: Josef S Smolen, Chenglong Han, M Bala, Ravinder N. Maini, Joachim R. Kalden, D. van der Heijde, F. C. Breedveld, Daniel E. Fürst, Peter E. Lipsky, ATTRACT Study Group - Arthritis & Rheumatism 2005 cited by 462

  19. Regulation of Cytokines, Cytokine Inhibitors, and Acute-Phase Proteins Following Anti-TNF-α Therapy in Rheumatoid Arthritis

    Authors: P. Charles, Michael J. Elliott, Diana Davis, A. R. Potter, Joachim R. Kalden, Christian Antoni, Ferdinand C. Breedveld, Josef S Smolen, Gabriele Eberl, Kim deWoody, Marc Feldmann, Ravinder N. Maini - The Journal of Immunology 1999 cited by 434

  20. Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study

    Authors: Alberto Cauli, Dafna D. Gladman, Alessandro Mathieu, Ignazio Olivieri, Giovanni Porru, Paul P. Tak, Claudia Sardu, Ilona Újfalussy, Raffaele Scarpa, Antonio Marchesoni, William J. Taylor, Antonio Spadaro, J.L. Fernández-Sueiro, Carlo Salvarani, Joachim R. Kalden, Ennio Lubrano, Sueli Carneiro, F. Desiati, John A. Flynn, Salvatore D’Angelo, Alessandra Vacca, Arno W. R. van Kuijk, Mariagrazia Catanoso, M. Gruenke, Rosario Peluso, Wendy J. Parsons, Nicola Ferrara, Paolo Contu, Philip Helliwell, Philip J. Mease, Philip J. Mease - The Journal of Rheumatology 2011 cited by 136

  21. Expression of interleukin‐21 receptor in epidermis from patients with systemic sclerosis

    Authors: Jörg H. W. Distler, Astrid Jüngel, Otylia Kowal‐Bielecka, Beat A. Michel, Renate E. Gay, Haiko Sprott, Marco Matucci‐Cerinic, Meike Chilla, Kristian Reich, Joachim R. Kalden, Ulf Müller‐Ladner, Hanns M. Lorenz, Steffen Gay, Oliver Distler - Arthritis & Rheumatism 2005 cited by 136

  22. Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018

    Authors: Kevin Winthrop, Michael E. Weinblatt, Mary K. Crow, Gerd R Burmester, Philip J. Mease, Alexander So, Vivian P. Bykerk, Ronald van Vollenhoven, Maxime Dougados, Jonathan Kay, Xavier Mariette, Joachim Sieper, Fritz Melchers, Bruce N. Cronstein, Ethan M. Shevach, Ferdinand C. Breedfeld, Joachim R. Kalden, Josef S Smolen, Daniel E. Fürst - Annals of the Rheumatic Diseases 2019 cited by 62

  23. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European community

    Authors: Claudio Vitali, Stefano Bombardieri, Haralampos Μ. Moutsopoulos, G. Balestrieri, W. Bencivelli, Robert M. Bernstein, K. Bjerrum, S. Braga, Joaquı́n Coll, Salvatore De Vita, Alexandros A. Drosos, Michael Ehrenfeld, P.Y. Hatron, Elaine M. Hay, David Isenberg, Anne Janin, Joachim R. Kalden, L Kater, Yrjö T. Konttinen, Peter J. Maddison, Ravinder N. Maini, R. Manthorpe, Olivier Meyer, Pierantonio Ostuni, Yvon Pennec, Jan Ulrik Prause, Andrea Richards, B Sauvezie, Morten Schiødt, Maria Elisa Sciuto, Crispian Scully, Yehuda Shoenfeld, Fotini N. Skopouli, Josef S Smolen, M L Snaith, Moshe Tishler, S Todesco, Guido Valesini, Patrick J Venables, Marie J. Wattiaux, Pierre Youinou - Arthritis & Rheumatism 1993 cited by 1,441

  24. Defective Suppressor Function of Human CD4+ CD25+ Regulatory T Cells in Autoimmune Polyglandular Syndrome Type II

    Authors: Martin Kriegel, Tobias Lohmann, Christoph Gabler, Norbert Blank, Joachim R. Kalden, Hanns‐Martin Lorenz - The Journal of Experimental Medicine 2004 cited by 350